{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T07:19:54Z","timestamp":1794899994885,"version":"4.9.1"},"reference-count":69,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"32","license":[{"start":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T00:00:00Z","timestamp":1754611200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,8,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Rheumatoid arthritis (RA) is a chronic autoimmune disorder associated with various comorbidities, including nonalcoholic fatty liver disease (NAFLD). The prevalence of NAFLD in RA patients remains inconsistently reported, necessitating a comprehensive meta-analysis to estimate its true prevalence. This study aimed to assess the prevalence of NAFLD in patients with RA by synthesizing data from multiple studies.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A systematic search was performed across PubMed, Scopus, and Web of Science for studies published up to January 2025. Eligible studies that reported on the prevalence of NAFLD in RA patients were included. A random-effects model was applied, and sensitivity analyses were conducted to test the robustness of the findings. Statistical analyses were performed using Comprehensive Meta-Analysis Software (CMA) version 4<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      The pooled prevalence of NAFLD\/nonalcoholic steatohepatitis (NASH) in RA patients was found to be 22.8% (95% CI = 7.8%\u201350.8%) with substantial heterogeneity (\n                      <jats:italic toggle=\"yes\">I<\/jats:italic>\n                      \u00b2\u2005=\u200599.52%). The prediction interval for the prevalence of NAFLD\/NASH ranged from 1% to 99%. Subgroup analysis showed varying prevalence rates based on diagnostic modalities: 33.3% for FibroScan, 43.9% for liver biopsy, and 30.5% for ultrasonography.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>The prevalence of NAFLD is remarkable in RA patients, with varying rates depending on diagnostic methods. The substantial heterogeneity observed across studies, reflected in the wide range of the prediction interval, underscores the need for further studies to provide a more precise estimate. Given the notable prevalence of NAFLD\/NASH in RA patients, clinicians are suggested to consider this issue by implementing regular liver screening as a valuable part of RA patient care. More studies are essential to offer a clearer and more consistent understanding of NAFLD\/NASH in this population.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000043641","type":"journal-article","created":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T19:01:22Z","timestamp":1755198082000},"page":"e43641","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":9,"title":["Prevalence of nonalcoholic fatty liver disease in rheumatoid arthritis: An updated systematic review and meta-analysis"],"prefix":"10.1097","volume":"104","author":[{"given":"Abinash","family":"Mahapatro","sequence":"first","affiliation":[{"name":"Hi-Tech Medical College and Hospital, Rourkela, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Jafari","sequence":"additional","affiliation":[{"name":"Student Research Committee, School of Medicine, Anzali International Campus, Guilan University of Medical Sciences, Rasht, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herby","family":"Jeanty","sequence":"additional","affiliation":[{"name":"The Brooklyn Hospital Center, Brooklyn, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satabdi","family":"Sahu","sequence":"additional","affiliation":[{"name":"MKCG Medical College and Hospital, Berhampur, Ganjam, Odisha, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Eslampanah","sequence":"additional","affiliation":[{"name":"Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Amouzadeh-Lichahi","sequence":"additional","affiliation":[{"name":"Student Research Committee, School of Medicine, Anzali International Campus, Guilan University of Medical Sciences, Rasht, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohit","family":"Mirchandani","sequence":"additional","affiliation":[{"name":"Montefiore Medical Center Wakefield Campus, Bronx, NY"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nakka","family":"Raghuma","sequence":"additional","affiliation":[{"name":"GSL Medical College and General Hospital, Rajamahendravaram, Andhra Pradesh, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhruvan","family":"Patel","sequence":"additional","affiliation":[{"name":"Drexel University College of Medicine, Philadelphia, PA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elan","family":"Mohanty","sequence":"additional","affiliation":[{"name":"Mary Medical Center Apple Valley, Apple Valley, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishan","family":"Patel","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Riverside Community Hospital, Riverside, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reyhaneh","family":"Pasandipour","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyyed Mohammad","family":"Hashemi","sequence":"additional","affiliation":[{"name":"Cardiovascular Research Center, Hormozgan University of Medical Sciences, Bandar Abbas, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4985-2899","authenticated-orcid":false,"given":"Ehsan","family":"Amini-Salehi","sequence":"additional","affiliation":[{"name":"Gastrointestinal and Liver Diseases Research Center, Guilan University of, Medical Sciences, Rasht, Iran."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20261117","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41413-018-0016-9","article-title":"Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies.","volume":"6","author":"Guo","year":"2018","journal-title":"Bone Res"},{"key":"R2-20261117","doi-asserted-by":"crossref","first-page":"e509","DOI":"10.1002\/mco2.509","article-title":"Rheumatoid arthritis: pathogenesis and therapeutic advances.","volume":"5","author":"Gao","year":"2024","journal-title":"MedComm (2020)"},{"key":"R3-20261117","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3899\/jrheum.2023-0349","article-title":"Metabolic syndrome is associated with an increased risk of rheumatoid arthritis: a prospective cohort study including 369,065 participants.","volume":"51","author":"Luo","year":"2024","journal-title":"J Rheumatol"},{"key":"R4-20261117","doi-asserted-by":"crossref","first-page":"5859","DOI":"10.2147\/IJGM.S490916","article-title":"Prevalence and risk factors of cardiovascular disease in rheumatoid arthritis patients: a comparative analysis of real-world data.","volume":"17","author":"Tekeoglu","year":"2024","journal-title":"Int J Gen Med"},{"key":"R5-20261117","doi-asserted-by":"crossref","first-page":"e863","DOI":"10.52225\/narra.v4i3.863","article-title":"Burden of rheumatic diseases among people with diabetes: a systematic review and meta-analysis.","volume":"4","author":"Mamadapur","year":"2024","journal-title":"Narra J"},{"key":"R6-20261117","doi-asserted-by":"crossref","first-page":"e004246","DOI":"10.1136\/rmdopen-2024-004246","article-title":"Prednisone use, disease activity and the occurrence of hyperglycaemia and diabetes in patients with early rheumatoid arthritis: a 10-year subanalysis of the BeSt study.","volume":"10","author":"van der Pol","year":"2024","journal-title":"RMD Open"},{"key":"R7-20261117","doi-asserted-by":"crossref","first-page":"e079296","DOI":"10.1136\/bmjopen-2023-079296","article-title":"Increased NAFLD risk in newly diagnosed patients with RA during the first 4 years of follow-up: a nationwide, population-based cohort study.","volume":"14","author":"Ho","year":"2024","journal-title":"BMJ Open"},{"key":"R8-20261117","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1007\/s10620-023-08225-4","article-title":"Prevalence of steatotic liver disease among US adults with rheumatoid arthritis.","volume":"69","author":"Vassilopoulos","year":"2024","journal-title":"Dig Dis Sci"},{"key":"R9-20261117","doi-asserted-by":"crossref","first-page":"103043","DOI":"10.1016\/j.arcmed.2024.103043","article-title":"Global prevalence of nonalcoholic fatty liver disease: an updated review meta-analysis comprising a population of 78 million from 38 countries.","volume":"55","author":"Amini-Salehi","year":"2024","journal-title":"Arch Med Res"},{"key":"R10-20261117","first-page":"1600","article-title":"The prevalence of non-alcoholic fatty liver disease in Iranian children and adult population: a systematic review and meta-analysis.","volume":"52","author":"Hassanipour","year":"2023","journal-title":"Iran J Public Health"},{"key":"R11-20261117","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/s41387-024-00281-7","article-title":"The effects of gut microbiome manipulation on glycemic indices in patients with non-alcoholic fatty liver disease: a comprehensive umbrella review.","volume":"14","author":"Vakilpour","year":"2024","journal-title":"Nutr Diabetes"},{"key":"R12-20261117","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s13643-023-02299-x","article-title":"Effects of gut microbial therapy on lipid profile in individuals with non-alcoholic fatty liver disease: an umbrella meta-analysis study.","volume":"12","author":"Naghipour","year":"2023","journal-title":"Syst Rev"},{"key":"R13-20261117","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.clnesp.2023.07.087","article-title":"Anti-inflammatory effects of probiotics and synbiotics on patients with non-alcoholic fatty liver disease: an umbrella study on meta-analyses.","volume":"57","author":"Mahapatro","year":"2023","journal-title":"Clin Nutr ESPEN"},{"key":"R14-20261117","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.clnesp.2024.11.011","article-title":"Modulation of inflammatory markers in type 2 diabetes mellitus through gut microbiome-targeted interventions: an umbrella review on meta-analyses.","volume":"65","author":"Habibi","year":"2025","journal-title":"Clin Nutr ESPEN"},{"key":"R15-20261117","doi-asserted-by":"crossref","first-page":"e004546","DOI":"10.1136\/rmdopen-2024-004546","article-title":"Biological use influences the impact of inflammation on risk of major adverse cardiovascular events in rheumatoid arthritis.","volume":"10","author":"Karpouzas","year":"2024","journal-title":"RMD Open"},{"key":"R16-20261117","first-page":"1707","article-title":"Pathogenesis of rheumatoid arthritis: one year in review 2024.","volume":"42","author":"D\u2019Orazio","year":"2024","journal-title":"Clin Exp Rheumatol"},{"key":"R17-20261117","doi-asserted-by":"crossref","first-page":"387","DOI":"10.62347\/KMSA5983","article-title":"Non-alcoholic fatty liver disease: pathogenesis and models.","volume":"16","author":"Zhong","year":"2024","journal-title":"Am J Transl Res"},{"key":"R18-20261117","doi-asserted-by":"crossref","first-page":"1388557","DOI":"10.3389\/fnut.2024.1388557","article-title":"Dietary inflammatory index and the risks of non-alcoholic fatty liver disease: a systematic review and meta-analysis.","volume":"11","author":"Zhang","year":"2024","journal-title":"Front Nutr"},{"key":"R19-20261117","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.amjms.2017.03.014","article-title":"Methotrexate hepatotoxicity and the impact of nonalcoholic fatty liver disease.","volume":"354","author":"Shetty","year":"2017","journal-title":"Am J Med Sci"},{"key":"R20-20261117","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/s41584-022-00883-4","article-title":"Busting the myth of methotrexate chronic hepatotoxicity.","volume":"19","author":"Di Martino","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"R21-20261117","first-page":"4344905","article-title":"Glucocorticosteroids and the risk of NAFLD in inflammatory bowel disease.","volume":"2022","author":"Jarmakiewicz-Czaja","year":"2022","journal-title":"Can J Gastroenterol Hepatol"},{"key":"R22-20261117","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1007\/s10067-020-05456-y","article-title":"Methotrexate use does not increase the prevalence of hepatic steatosis: a real-world retrospective nested case-control study.","volume":"40","author":"Choi","year":"2021","journal-title":"Clin Rheumatol"},{"key":"R23-20261117","doi-asserted-by":"crossref","first-page":"723","DOI":"10.12669\/pjms.36.4.1984","article-title":"Fatty liver in Pakistani cohort with rheumatoid arthritis.","volume":"36","author":"Wagan","year":"2020","journal-title":"Pak J Med Sci"},{"key":"R24-20261117","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/eci.12798","article-title":"Complement C3 and fatty liver disease in Rheumatoid arthritis patients: a cross-sectional study.","volume":"47","author":"Ursini","year":"2017","journal-title":"Eur J Clin Invest"},{"key":"R25-20261117","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/2046-4053-4-1","article-title":"Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement.","volume":"4","author":"Moher","year":"2015","journal-title":"Syst Rev"},{"key":"R29-20261117","doi-asserted-by":"crossref","first-page":"699","DOI":"10.4254\/wjh.v15.i5.699","article-title":"Liver steatosis in patients with rheumatoid arthritis treated with methotrexate is associated with body mass index.","volume":"15","author":"Castiella","year":"2023","journal-title":"World J Hepatol"},{"key":"R30-20261117","doi-asserted-by":"crossref","first-page":"100003","DOI":"10.1016\/j.clirex.2020.100003","article-title":"A pragmatic non-invasive assessment of liver fibrosis in patients with psoriasis, rheumatoid arthritis or Crohn\u2019s disease receiving methotrexate therapy.","volume":"44","author":"Cervoni","year":"2020","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"R31-20261117","doi-asserted-by":"crossref","first-page":"1759720X211042739","DOI":"10.1177\/1759720X211042739","article-title":"Prevalence and risk factors of moderate to severe hepatic steatosis in patients with rheumatoid arthritis: an ultrasonography cross-sectional case\u2013control study.","volume":"13","author":"Erre","year":"2021","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"R32-20261117","doi-asserted-by":"crossref","first-page":"e15003","DOI":"10.1111\/1756-185X.15003","article-title":"Antirheumatic drugs and the risk of nonalcoholic fatty liver disease in patients with rheumatoid arthritis: a nationwide, population-based cohort study.","volume":"27","author":"Meng","year":"2024","journal-title":"Int J Rheum Dis"},{"key":"R33-20261117","doi-asserted-by":"crossref","first-page":"50","DOI":"10.30841\/2786-720X.4.2023.297030","article-title":"Dyslipidemia and nonalcoholic fatty liver disease in rheumatoid arthritis patients.","volume":"2023","author":"Khimion","year":"2023","journal-title":"Fam Med Eur Pract"},{"key":"R34-20261117","doi-asserted-by":"crossref","first-page":"e0203084","DOI":"10.1371\/journal.pone.0203084","article-title":"Non-alcoholic steatohepatitis-like pattern in liver biopsy of rheumatoid arthritis patients with persistent transaminitis during low-dose methotrexate treatment.","volume":"13","author":"Mori","year":"2018","journal-title":"PLoS One"},{"key":"R35-20261117","doi-asserted-by":"crossref","first-page":"rkaa020","DOI":"10.1093\/rap\/rkaa020","article-title":"Incidence, predictive factors and severity of methotrexate-related liver injury in rheumatoid arthritis: a longitudinal cohort study.","volume":"4","author":"Mori","year":"2020","journal-title":"Rheumatol Adv Pract"},{"key":"R36-20261117","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jid.2017.10.024","article-title":"Risk of incident liver disease in patients with psoriasis, psoriatic arthritis, and rheumatoid arthritis: a population-based study.","volume":"138","author":"Ogdie","year":"2018","journal-title":"J Invest Dermatol"},{"key":"R37-20261117","doi-asserted-by":"crossref","first-page":"823763","DOI":"10.1155\/2014\/823763","article-title":"Methotrexate-associated nonalcoholic fatty liver disease with transaminitis in rheumatoid arthritis.","volume":"2014","author":"Sakthiswary","year":"2014","journal-title":"ScientificWorldJournal"},{"key":"R38-20261117","doi-asserted-by":"crossref","first-page":"42","DOI":"10.4103\/injr.injr_112_18","article-title":"A cross-sectional study of different rheumatic diseases and their respective comorbidities at a tertiary care hospital in India.","volume":"14","author":"Yadav","year":"2019","journal-title":"Indian J Rheumatol"},{"key":"R39-20261117","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1136\/annrheumdis-2022-eular.2999","article-title":"Comparison of metabolic dysfunction-associated fatty liver disease with non-alcoholic fatty liver disease in identifying cardiovascular risk in Chinese individuals with rheumatoid arthritis.","volume":"81","author":"Zou","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"R40-20261117","doi-asserted-by":"crossref","first-page":"1149665","DOI":"10.3389\/fphar.2023.1149665","article-title":"Non-alcoholic fatty liver disease combined with rheumatoid arthritis exacerbates liver fibrosis by stimulating co-localization of PTRF and TLR4 in rats.","volume":"14","author":"Zhang","year":"2023","journal-title":"Front Pharmacol"},{"key":"R41-20261117","doi-asserted-by":"crossref","first-page":"997270","DOI":"10.3389\/fimmu.2022.997270","article-title":"Nonalcoholic fatty liver disease in inflammatory arthritis: relationship with cardiovascular risk.","volume":"13","author":"Barbarroja","year":"2022","journal-title":"Front Immunol"},{"key":"R42-20261117","doi-asserted-by":"crossref","first-page":"2353","DOI":"10.1016\/j.cgh.2023.11.041","article-title":"Prevalence of nonalcoholic fatty liver disease in patients with rheumatoid arthritis: more evidence is needed.","volume":"22","author":"Li","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R43-20261117","doi-asserted-by":"crossref","first-page":"152840","DOI":"10.1016\/j.tox.2021.152840","article-title":"Hepatotoxic potentials of methotrexate: understanding the possible toxicological molecular mechanisms.","volume":"458","author":"Ezhilarasan","year":"2021","journal-title":"Toxicology"},{"key":"R44-20261117","doi-asserted-by":"crossref","first-page":"e28468","DOI":"10.1016\/j.heliyon.2024.e28468","article-title":"Nonalcoholic steatohepatitis: a comprehensive updated review of risk factors, symptoms, and treatment.","volume":"10","author":"Savari","year":"2024","journal-title":"Heliyon"},{"key":"R45-20261117","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1093\/cvr\/cvad095","article-title":"Non-alcoholic fatty liver disease: pathophysiological concepts and treatment options.","volume":"119","author":"Grander","year":"2023","journal-title":"Cardiovasc Res"},{"key":"R46-20261117","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3390\/metabo14030153","article-title":"Interleukins: pathogenesis in non-alcoholic fatty liver disease.","volume":"14","author":"Rafaqat","year":"2024","journal-title":"Metabolites"},{"key":"R47-20261117","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s13679-023-00519-y","article-title":"The role of tumor necrosis factor-alpha in the pathogenesis and treatment of nonalcoholic fatty liver disease.","volume":"12","author":"Vachliotis","year":"2023","journal-title":"Curr Obes Rep"},{"key":"R48-20261117","doi-asserted-by":"crossref","first-page":"1759720X241283340","DOI":"10.1177\/1759720X241283340","article-title":"What have we learnt from the inhibition of IL-6 in RA and what are the clinical opportunities for patient outcomes?","volume":"16","author":"Taylor","year":"2024","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"R49-20261117","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.molmed.2018.03.005","article-title":"IL-1 family cytokine pathways underlying NAFLD: towards new treatment strategies.","volume":"24","author":"Mirea","year":"2018","journal-title":"Trends Mol Med"},{"key":"R50-20261117","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.intimp.2019.02.029","article-title":"Taraxasterol suppresses inflammation in IL-1\u03b2-induced rheumatoid arthritis fibroblast-like synoviocytes and rheumatoid arthritis progression in mice.","volume":"70","author":"Chen","year":"2019","journal-title":"Int Immunopharmacol"},{"key":"R51-20261117","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1186\/s12902-024-01675-5","article-title":"Prevalence and contributing factors of metabolic syndrome in rheumatoid arthritis patients.","volume":"24","author":"Bagheri-Hosseinabadi","year":"2024","journal-title":"BMC Endocr Disord"},{"key":"R52-20261117","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.3390\/medicina59061029","article-title":"Correlation between cumulative methotrexate dose, metabolic syndrome and hepatic fibrosis detected by FibroScan in rheumatoid arthritis patients.","volume":"59","author":"Lertnawapan","year":"2023","journal-title":"Medicina (Kaunas)"},{"key":"R53-20261117","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/art.43034","article-title":"Metabolic syndrome, adipokines, and response to advanced therapies in rheumatoid arthritis.","volume":"77","author":"Baker","year":"2025","journal-title":"Arthritis Rheumatol"},{"key":"R54-20261117","doi-asserted-by":"crossref","first-page":"101092","DOI":"10.1016\/j.molmet.2020.101092","article-title":"Dysregulated lipid metabolism links NAFLD to cardiovascular disease.","volume":"42","author":"Deprince","year":"2020","journal-title":"Mol Metab"},{"key":"R55-20261117","doi-asserted-by":"crossref","first-page":"329","DOI":"10.3899\/jrheum.2023-1210","article-title":"Metabolic syndrome: a predisposing factor for rheumatoid arthritis.","volume":"51","author":"Gonz\u00e1lez-Gay","year":"2024","journal-title":"J Rheumatol"},{"key":"R56-20261117","doi-asserted-by":"crossref","first-page":"111239","DOI":"10.1016\/j.humimm.2025.111239","article-title":"Alterations in gut microbiota in rheumatoid arthritis patients with interstitial lung disease: a comparative study.","volume":"86","author":"Zhong","year":"2025","journal-title":"Hum Immunol"},{"key":"R57-20261117","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1002\/art.42616","article-title":"Alteration of gut microbiota in individuals at high-risk for rheumatoid arthritis associated with disturbed metabolome and the initiation of arthritis through the triggering of mucosal immunity imbalance.","volume":"75","author":"Luo","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"R58-20261117","doi-asserted-by":"crossref","first-page":"81","DOI":"10.12938\/bmfh.18-032","article-title":"The role of gut microbiota in non-alcoholic fatty liver disease: pathways of mechanisms.","volume":"38","author":"Jasirwan","year":"2019","journal-title":"Biosci Microbiota Food Health"},{"key":"R59-20261117","doi-asserted-by":"crossref","first-page":"4835189","DOI":"10.1155\/2017\/4835189","article-title":"Intestinal dysbiosis and rheumatoid arthritis: a link between gut microbiota and the pathogenesis of rheumatoid arthritis.","volume":"2017","author":"Horta-Baas","year":"2017","journal-title":"J Immunol Res"},{"key":"R60-20261117","doi-asserted-by":"crossref","first-page":"1092118","DOI":"10.3389\/fcimb.2023.1092118","article-title":"Gut-joint axis: gut dysbiosis can contribute to the onset of rheumatoid arthritis via multiple pathways.","volume":"13","author":"Romero-Figueroa","year":"2023","journal-title":"Front Cell Infect Microbiol"},{"key":"R61-20261117","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1186\/s13075-022-02946-z","article-title":"The biological activity of serum bacterial lipopolysaccharides associates with disease activity and likelihood of achieving remission in patients with rheumatoid arthritis.","volume":"24","author":"Parantainen","year":"2022","journal-title":"Arthritis Res Ther"},{"key":"R62-20261117","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1002\/hep.31056","article-title":"Increased liver localization of lipopolysaccharides in human and experimental NAFLD.","volume":"72","author":"Carpino","year":"2020","journal-title":"Hepatology"},{"key":"R63-20261117","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.3390\/nu16183215","article-title":"Gut dysbiosis and dietary interventions in rheumatoid arthritis-a narrative review.","volume":"16","author":"Bakinowska","year":"2024","journal-title":"Nutrients"},{"key":"R64-20261117","doi-asserted-by":"crossref","first-page":"591365","DOI":"10.3389\/fimmu.2020.591365","article-title":"Use of TNF inhibitors in rheumatoid arthritis and implications for the periodontal status: for the benefit of both?","volume":"11","author":"Zamri","year":"2020","journal-title":"Front Immunol"},{"key":"R65-20261117","doi-asserted-by":"crossref","first-page":"1229570","DOI":"10.3389\/fimmu.2023.1229570","article-title":"Influence of genetically predicted autoimmune diseases on NAFLD.","volume":"14","author":"Xu","year":"2023","journal-title":"Front Immunol"},{"key":"R66-20261117","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jcmgh.2021.11.007","article-title":"TM6SF2\/PNPLA3\/MBOAT7 loss-of-function genetic variants impact on NAFLD development and progression both in patients and in in vitro models.","volume":"13","author":"Longo","year":"2022","journal-title":"Cell Mol Gastroenterol Hepatol"},{"key":"R67-20261117","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1002\/art.40490","article-title":"Modulation of inflammatory arthritis in mice by gut microbiota through mucosal inflammation and autoantibody generation.","volume":"70","author":"Jubair","year":"2018","journal-title":"Arthritis Rheumatol"},{"key":"R68-20261117","doi-asserted-by":"crossref","first-page":"2789","DOI":"10.1016\/j.cgh.2023.02.021","article-title":"Prevalence of nonalcoholic fatty liver disease in patients with rheumatoid arthritis: a systematic review and meta-analysis.","volume":"21","author":"Zamani","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R69-20261117","doi-asserted-by":"crossref","first-page":"16820","DOI":"10.3748\/wjg.v20.i45.16820","article-title":"Non-invasive diagnosis of advanced fibrosis and cirrhosis.","volume":"20","author":"Sharma","year":"2014","journal-title":"World J Gastroenterol"},{"key":"R70-20261117","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1007\/s00296-021-05059-z","article-title":"Usefulness of noninvasive diagnostic procedures for assessment of methotrexate hepatotoxicity in patients with rheumatoid arthritis.","volume":"42","author":"Frankowski","year":"2022","journal-title":"Rheumatol Int"},{"key":"R71-20261117","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2174\/1573397115666190121135940","article-title":"Lifestyle modification in rheumatoid arthritis: dietary and physical activity recommendations based on evidence.","volume":"15","author":"Chehade","year":"2019","journal-title":"Curr Rheumatol Rev"},{"key":"R72-20261117","doi-asserted-by":"crossref","first-page":"7179","DOI":"10.3390\/jcm11237179","article-title":"Lifestyle factors and their influence on rheumatoid arthritis: a narrative review.","volume":"11","author":"Sch\u00e4fer","year":"2022","journal-title":"J Clin Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000043641","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T07:01:23Z","timestamp":1794898883000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000043641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,8]]},"references-count":69,"journal-issue":{"issue":"32","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000043641","relation":{},"ISSN":["1536-5964","0025-7974"],"issn-type":[{"value":"1536-5964","type":"electronic"},{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8,8]]},"assertion":[{"value":"2025-05-30","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-07-11","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}